SEC Form 4 · accession 0001609351-16-000013
Spark Therapeutics, Inc. · ONCE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lota S. Zoth
Director
Period of report
Jan 6, 2016
Accepted (ET)
Jan 8, 2016 · 4:05 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001609351
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $37.18 | Jan 6, 2016 | A | 12,000 | A | — | Jan 5, 2026 | Common Stock | 12,000 | 12,000 | D |
Explanation of responses
- F133% vests on January 6, 2017 and the remainder vests in equal quarterly installments over the following two years.